mTORC1 inhibitor

This page covers all mTORC1 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting mTORC1.

Targets

mTORC1

Phase 3 pipeline (1)

• AZD0486 · AstraZeneca · Oncology
  AZD0486 is a selective inhibitor of the mechanistic target of rapamycin complex 1 (mTORC1) that suppresses protein synthesis and cell proliferation in cancer cells.